ArticleOncotarget2018

Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.

Mengyao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.